Hints and tips:
Related Special Reports
...Still, that has not stopped investors from fretting about pipeline replacement at companies such as Bristol Myers Squibb (BMS), Sanofi and Roche....
...Myers Squibb Q1, Capital One Q1, Caterpillar Q1, Comcast Q1, Dassault Systemes Q1, Delivery Hero Q1 trading update, Deutsche Bank Q1, Dow Q1, Drax Group AGM and trading update, Inchcape Q1, Intel Q1, London...
...Bristol Myers Squibb trades on just seven times earnings while Pfizer is on 20 times. The frenzy for weight loss and diabetes medications is unlikely to fade....
...Oxford-based Exscientia is working with Sanofi and Bristol Myers Squibb, among others, and Insitro has a deal with Bristol Myers, while Owkin is also collaborating with Sanofi....
...In the pharmaceutical industry, big companies including AstraZeneca, AbbVie and Bristol Myers Squibb have announced about $25bn worth of biotech-related deals....
...Myers Squibb Q4, Charter Communications Q4, Chevron Q4, Cigna Group Q4, Danske Bank Q4, Deutsche Bank FY, Electrolux Q4, ExxonMobil Q4, Ferrari Q4, Japan Airlines Q3, KDDI Q3, Mitsui & Co Q3, Panasonic...
...Pharmaceutical groups Bristol Myers Squibb, Regeneron and AbbVie are also expected to release earnings....
...Bristol Myers Squibb says it expects to cancel some drug development programmes due to US government drug pricing rules that are due to be phased in from next year....
...Myers Squibb; and a Novartis drug to treat heart failure called Entresto....
...The chief executive of Bristol Myers Squibb has warned that the US pharmaceutical company could divert investment away from the UK due to the expansion of a levy designed to limit the NHS’s medicines bill...
...Myers Squibb to acquire Mirati in up to $5.8bn deal (Reuters) German auto group Schaeffler swoops for Vitesco with €3bn bid (FT) Big banks sit out LBO rebound after being stung by earlier buyouts (FT)...
...Myers Squibb Q2, Britvic Q3 trading statement, BT Group Q1 trading update, Groupe Casino H1, Centrica H1, CMC Markets Q1 trading update, Comcast Q2, CVS Group trading update, EDF H1, Elementis H1, Ford...
...Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series of bolt-on acquisitions by pharmaceutical companies looking to bolster their drug pipelines....
...GSK, Pfizer and Bristol Myers Squibb were among other big pharmaceutical companies that stopped trying to find treatments for some of humanity’s most inscrutable diseases....
...Last year, US drugmaker Bristol Myers Squibb said it could divert investment away from the UK because of the increasing clawbacks....
...Sanofi and Bristol Myers Squibb are among those that have struck partnerships with AI-focused start-ups but an acquisition is unusual....
...A coalition of ethical investors have asked Johnson & Johnson, Merck, Pfizer, Eli Lilly, Gilead, Amgen, Regeneron, Bristol Myers Squibb and AbbVie to publish a report on the process they follow when applying...
...Cancer, stroke and diabetes medications made by Merck, Johnson & Johnson and Bristol Myers Squibb are among the first tranche of medications selected for negotiation....
...Bristol Myers Squibb already signed a $1.2bn deal with AI company Exscientia last year, and both Owkin and Exscientia recently signed partnerships with French drugmaker Sanofi....
...Myers Squibb Q4, BT Group Q3 trading update, Canada Goose Q3, Chubb Q4, ConocoPhillips Q4, Danske Bank Q4, Dassault Systemes Q4, Deutsche Bank FY, Electrolux FY, Eli Lilly & Co Q4, Estee Lauder Q2, Fast...
...SeaGen also recently signed a partnership with French drugmaker Sanofi and has agreements with Takeda and Bristol Myers Squibb among others. SeaGen declined to comment....
...The conditions appear ripe for an M&A boom: big drugmakers are sitting on almost $300bn of cash and many, including Merck and Bristol-Myers-Squibb, need to refill their pipelines because of major patent...
...I don’t want to go help Bristol Myers Squibb, you know, improve their email.” Newport’s two upcoming titles — Slow Productivity and The Deep Life — are what he calls his “midlife crisis books”....
...It exited its position in generic drugs maker Teva and sold more than 70 per cent of its remaining shares in AbbVie and Bristol-Myers Squibb....
...Myers Squibb Q2, British American Tobacco H1, Carrefour Q2, Credit Suisse Q2, Danone H1, Deutsche Bank Q2, Deutsche Börse Q2, Equinor Q2, Ford Motor Q2, GlaxoSmithKline Q2, Holcim H1, Iberdrola H1, Kering...
International Edition